Back to top
more

Edwards Lifesciences (EW)

(Delayed Data from NYSE)

$68.54 USD

68.54
10,204,861

+4.00 (6.20%)

Updated Oct 8, 2024 04:00 PM ET

After-Market: $68.53 -0.01 (-0.01%) 5:32 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.68%
2Buy17.55%
3Hold9.21%
4Sell4.93%
5Strong Sell2.36%
S&P50010.96%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

C Value F Growth F Momentum F VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 30% (76 out of 252)

Industry: Medical - Instruments

Better trading starts here.

Zacks News

Sweta Jaiswal headshot

4 MedTech Stocks to Counter Mounting US-China Trade Tensions

In the wake of the impact of the U.S.-China trade war on the MedTech space, we have doubled down on some stocks which offer a safe haven to investors.

    Here's Why You Should Add Edwards Lifesciences Right Away

    We are upbeat about the continued strength in Edwards Lifesciences' (EW) THVT business.

      Edwards Lifesciences (EW) in Focus: Stock Moves 7.7% Higher

      Edwards Lifesciences (EW) saw a big move last session, as its shares jumped nearly 8% on the day, amid huge volumes.

        Kevin Cook headshot

        Bull of the Day: Penumbra (PEN)

        Innovation in stroke treatment with catheter-based technologies has launched a new rocket of med-tech

          Here's Why You Should Steer Clear of AmerisourceBergen Now (Revised)

          AmerisourceBergen (ABC) continues to witness headwinds due to slowdown in hepatitis C revenues and conversion of branded drugs to the lower price generics.

            Edwards Lifesciences (EW) Q2 Earnings Beat, Revenues Miss

            Edwards Lifesciences (EW) gains from THVT strength on continued therapy adoption across all geographies in Q2.

              Medical Product Earnings Lineup for Jul 26: BAX, EW & More

              Streak of regulatory developments and deep R&D focus are likely to drive the Medical Product industry this earnings season. Here we take a quick look at four Medical Product majors that are going to release earnings results.

                Can R&D Focus Drive DENTSPLY SIRONA's (XRAY) Q2 Earnings?

                DENTSPLY SIRONA's (XRAY) continued focus on research and development and strategic buyouts are likely to drive Q2 results.

                  What's in Store for Cerner (CERN) This Earnings Season?

                  Cerner's (CERN) Q2 results are likely to show softer performance owing to declining revenues across core business segments.

                    What's in Store for AmerisourceBergen (ABC) in Q3 Earnings?

                    AmerisourceBergen's (ABC) Q3 results are likely to be driven by its core Pharmaceutical Distribution business; a competitive industry is a headwind.

                      Will Edwards' (EW) Steady Overall Growth Drive Q2 Earnings?

                      Edwards Lifesciences (EW) expected to gain from strength in all business segments and geographies in Q2.

                        Can BD Medical Drive Becton, Dickinson's (BDX) Q3 Earnings?

                        Becton, Dickinson's (BDX) core BD Medical likely to register solid results in Q3; a possible decline in BD Life Sciences raises concern.

                          Can Business Services Aid athenahealth's (ATHN) Q2 Earnings?

                          athenahealth's (ATHN) core Business Services unit is likely to drive growth in Q2; the company's focus on cloud-based services is encouraging.

                            Can Overall Growth Drive Align Technology (ALGN) Q2 Earnings?

                            Align Technology (ALGN) likely to gain from strength in Invisalign space as well as Scanner and Service business in Q2.

                              Here's Why You Should Add Edwards Lifesciences (EW) Now

                              We are upbeat about Edwards Lifesciences' (EW) strong transcatheter valve sales in the domestic market as well as overseas.

                                Kevin Cook headshot

                                Bear of the Day: Barrick Gold (ABX)

                                Growth estimates were falling when gold was rising, thus not surprising to see them slip further

                                  Sweta Killa headshot

                                  Should iShares Morningstar Mid-Cap Growth ETF (JKH) Be on Your Investing Radar?

                                  Style Box ETF report for JKH

                                    Kevin Cook headshot

                                    How to Play the New Hawkish Fed

                                    If you understand what stock market players are afraid of, you can ride the market to higher gains this summer.

                                      Why Is Edwards Lifesciences (EW) Up 1.5% Since Its Last Earnings Report?

                                      Edwards Lifesciences (EW) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

                                        Edwards Lifesciences (EW) Q1 Earnings Beat, Revenues Miss

                                        Edwards Lifesciences (EW) gains from THVT strength on continued therapy adoption across all geographies in Q1.

                                          Why Earnings Season Could Be Great for Edwards Lifesciences (EW)

                                          Edwards Lifesciences (EW) is seeing favorable earnings estimate revision activity as of late, which is generally a precursor to an earnings beat.

                                            Edwards Lifesciences' (EW) THVT Likely to Drive Q1 Earnings

                                            Edwards Lifesciences (EW) is expected to gain from strength in THVT on continued therapy adoption across all geographies in Q1.

                                              Can Steady Overall Growth Drive Align's (ALGN) Q1 Earnings?

                                              Align Technology (ALGN) is likely to gain from strength in the Invisalign space as well as Scanner and Service business in Q1.

                                                Here's Why You Should Steer Clear of AmerisourceBergen Now

                                                AmerisourceBergen (ABC) continues to witness headwinds due to slowdown in hepatitis C revenues and conversion of branded drugs to the lower price generics.

                                                  Medical Instrument Stocks Head-to-Head: Abiomed vs. STERIS

                                                  Here we take a look at the fundamentals of Abiomed (ABMD) and STERIS (STE) to determine which stock is a better pick in the Medical Instruments space.